On one hand, inhibition of METTL3 or METTL14 expression can reduce m6A level, enhance GSCs growth and self-renewal in vitro, as well as promote tumor-forming ability of GSCs in vivo [41, 45]. This evidence concerns the gene METTL14 and neoplasm.